Rafael Holdings is focused on developing novel cancer and immune therapies.
The company is a significant investor in two clinical-stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd., and is seeking opportunities to invest, acquire, or in-license additional therapeutic assets that address high unmet medical needs.
People
You last contacted this investor on .